Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy.

Choi, Jae Hee; Geum, Min Jung; Kang, Ji Eun; Park, Nam Gi; Oh, Yun Kyoung; Rhie, Sandy Jeong

Choi, Jae Hee; Geum, Min Jung; Kang, Ji Eun; Park, Nam Gi; Oh, Yun Kyoung; Rhie, Sandy Jeong.

Afiliação

Choi JH; Division of Life and Pharmaceutical Sciences Graduate School, Ewha Womans University, Seoul 03760, Korea.
Geum MJ; Department of Pharmacy, Konkuk University Medical Center, Seoul 05030, Korea.
Kang JE; Graduate School of Clinical Biohealth, Ewha Womans University, Seoul 03760, Korea.
Park NG; Department of Pharmacy, Severance Hospital, Yonsei University Health System, Seoul 03722, Korea.
Oh YK; College of Pharmacy, Ewha Womans University, Seoul 03760, Korea.
Rhie SJ; Department of Pharmacy, National Medical Center, Seoul 04564, Korea.

Pharmaceuticals (Basel) ; 14(11)2021 Nov 22.

Article em En | MEDLINE | ID: mdl-34832982

Palavras-chave

adjuvant chemotherapy; breast cancer; cyclophosphamide; doxorubicin; granulocyte colony-stimulating factor; neutropenia; secondary prophylaxis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google